{"pmid":32417420,"title":"Algorithm for the classification of Covid-19 rashes.","text":["Algorithm for the classification of Covid-19 rashes.","J Am Acad Dermatol","Ortega-Quijano, Daniel","Jimenez-Cauhe, Juan","Selda-Enriquez, Gerald","Fernandez-Guarino, Montserrat","Fernandez-Nieto, Diego","32417420"],"journal":"J Am Acad Dermatol","authors":["Ortega-Quijano, Daniel","Jimenez-Cauhe, Juan","Selda-Enriquez, Gerald","Fernandez-Guarino, Montserrat","Fernandez-Nieto, Diego"],"date":"2020-05-18T11:00:00Z","year":2020,"_id":"32417420","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.jaad.2020.05.034","keywords":["algorithm","blanching","covid-19","dermographism","rash","teledermatology"],"topics":["Diagnosis"],"weight":1,"_version_":1667058206760763394,"score":9.490897,"similar":[{"pmid":32472459,"title":"Treatment algorithm for COVID-19: a multidisciplinary point of view.","text":["Treatment algorithm for COVID-19: a multidisciplinary point of view.","The novel coronavirus (Sars-CoV-2) pandemic has spread rapidly, from December to the end of March, to 185 countries, and there have been over 3,000,000 cases identified and over 200,000 deaths. For a proportion of hospitalized patients, death can occur within a few days, mainly for adult respiratory distress syndrome or multi-organ dysfunction syndrome. In these patients, clinical signs and symptoms, as well as laboratory abnormalities, suggest a cytokine storm syndrome in response to the viral infection. No current targeted treatment is yet available for COVID-19, an unknown disease up to 2 months ago, which challenges doctors and researchers to find new drugs or reallocate other treatments for these patients. Since the beginning of the COVID-19 outbreak, a growing body of information on diagnostic and therapeutic strategies has emerged, mainly based on preliminary experience on retrospective studies or small case series. Antivirals, antimalarials, corticosteroids, biotechnological and small molecules, convalescent plasma and anticoagulants are among the drugs proposed for the treatment or in tested for COVID-19. Given the complexity of this new condition, a multidisciplinary management seems to be the best approach. Sharing and integrating knowledge between specialists, to evaluate the correct timing and setting of every treatment, could greatly benefit our patients. We reviewed the literature, combining it with our experiences and our specialist knowledge, to propose a management algorithm, correlating the clinical features with laboratory and imaging findings to establish the right timing for each treatment.Key Points* Critically ill COVID-19 patients show signs of cytokine storm syndrome.* No current targeted therapy is available, but a lot of drugs are in tested.* A multidisciplinary approach is crucial to manage COVID-19.* Choosing the correct timing of treatment is of pivotal importance to avoid the most severe complications.","Clin Rheumatol","Galluccio, Felice","Ergonenc, Tolga","Garcia Martos, Alvaro","Allam, Abdallah El-Sayed","Perez-Herrero, Maria","Aguilar, Ricardo","Emmi, Giacomo","Spinicci, Michele","Terrancle Juan, Ignacio","Fajardo-Perez, Mario","32472459"],"abstract":["The novel coronavirus (Sars-CoV-2) pandemic has spread rapidly, from December to the end of March, to 185 countries, and there have been over 3,000,000 cases identified and over 200,000 deaths. For a proportion of hospitalized patients, death can occur within a few days, mainly for adult respiratory distress syndrome or multi-organ dysfunction syndrome. In these patients, clinical signs and symptoms, as well as laboratory abnormalities, suggest a cytokine storm syndrome in response to the viral infection. No current targeted treatment is yet available for COVID-19, an unknown disease up to 2 months ago, which challenges doctors and researchers to find new drugs or reallocate other treatments for these patients. Since the beginning of the COVID-19 outbreak, a growing body of information on diagnostic and therapeutic strategies has emerged, mainly based on preliminary experience on retrospective studies or small case series. Antivirals, antimalarials, corticosteroids, biotechnological and small molecules, convalescent plasma and anticoagulants are among the drugs proposed for the treatment or in tested for COVID-19. Given the complexity of this new condition, a multidisciplinary management seems to be the best approach. Sharing and integrating knowledge between specialists, to evaluate the correct timing and setting of every treatment, could greatly benefit our patients. We reviewed the literature, combining it with our experiences and our specialist knowledge, to propose a management algorithm, correlating the clinical features with laboratory and imaging findings to establish the right timing for each treatment.Key Points* Critically ill COVID-19 patients show signs of cytokine storm syndrome.* No current targeted therapy is available, but a lot of drugs are in tested.* A multidisciplinary approach is crucial to manage COVID-19.* Choosing the correct timing of treatment is of pivotal importance to avoid the most severe complications."],"journal":"Clin Rheumatol","authors":["Galluccio, Felice","Ergonenc, Tolga","Garcia Martos, Alvaro","Allam, Abdallah El-Sayed","Perez-Herrero, Maria","Aguilar, Ricardo","Emmi, Giacomo","Spinicci, Michele","Terrancle Juan, Ignacio","Fajardo-Perez, Mario"],"date":"2020-05-31T11:00:00Z","year":2020,"_id":"32472459","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1007/s10067-020-05179-0","keywords":["algorithm","covid-19","management","sars-cov-2"],"topics":["Treatment"],"weight":1,"_version_":1668255193320390656,"score":69.03827},{"pmid":32370065,"title":"Hybridization Chain Reactions Targeting the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).","text":["Hybridization Chain Reactions Targeting the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).","In this work, hybridization chain reactions (HCRs) toward Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) nucleocapsid phosphoproteins gene loci and human RNase P are proposed to provide an isothermal amplification screening tool. The proposed chain reactions target the complementary DNA (cDNA) of SARS-CoV-2, with loci corresponding to gold-standard polymerase chain reaction (PCR) loci. Four hybridization chain reaction reactions are demonstrated herein, targeting N1/N2/N3 loci and human RNase P. The design of the hybridization chain reaction, herein, is assisted with an algorithm. The algorithm helps to search target sequences with low local secondary structure and high hybridization efficiency. The loop domain of the fuel hairpin molecule H1 and H2, which are the tunable segments in such reactions, are used as an optimization parameter to improve the hybridization efficiency of the chain reaction. The algorithm-derived HCR reactions were validated with gel electrophoresis. All proposed reactions exhibit a hybridization complex with a molecular mass >1.5k base pairs, which is clear evidence of chain reaction. The hybridization efficiency trend revealed by gel electrophoresis corresponds nicely to the simulated data from the algorithm. The HCR reactions and the corresponding algorithm serve as a basis to further SARS-CoV-2 sensing applications and facilitate better screening strategies for the prevention of on-going pandemics.","Int J Mol Sci","Wu, Tzu-Heng","Chang, Chia-Chen","Yang, Ching-Hsu","Lin, Wei-Yin","Ee, Tan Joy","Lin, Chii-Wann","32370065"],"abstract":["In this work, hybridization chain reactions (HCRs) toward Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) nucleocapsid phosphoproteins gene loci and human RNase P are proposed to provide an isothermal amplification screening tool. The proposed chain reactions target the complementary DNA (cDNA) of SARS-CoV-2, with loci corresponding to gold-standard polymerase chain reaction (PCR) loci. Four hybridization chain reaction reactions are demonstrated herein, targeting N1/N2/N3 loci and human RNase P. The design of the hybridization chain reaction, herein, is assisted with an algorithm. The algorithm helps to search target sequences with low local secondary structure and high hybridization efficiency. The loop domain of the fuel hairpin molecule H1 and H2, which are the tunable segments in such reactions, are used as an optimization parameter to improve the hybridization efficiency of the chain reaction. The algorithm-derived HCR reactions were validated with gel electrophoresis. All proposed reactions exhibit a hybridization complex with a molecular mass >1.5k base pairs, which is clear evidence of chain reaction. The hybridization efficiency trend revealed by gel electrophoresis corresponds nicely to the simulated data from the algorithm. The HCR reactions and the corresponding algorithm serve as a basis to further SARS-CoV-2 sensing applications and facilitate better screening strategies for the prevention of on-going pandemics."],"journal":"Int J Mol Sci","authors":["Wu, Tzu-Heng","Chang, Chia-Chen","Yang, Ching-Hsu","Lin, Wei-Yin","Ee, Tan Joy","Lin, Chii-Wann"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32370065","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.3390/ijms21093216","keywords":["sars-cov-2","algorithm","hybridization chain reaction"],"topics":["Mechanism","Diagnosis"],"weight":1,"_version_":1666138496483459072,"score":52.896694},{"pmid":32294262,"title":"Comment on: Cutaneous manifestations in COVID-19: a first perspective. Safety concerns of clinical images and skin biopsies.","text":["Comment on: Cutaneous manifestations in COVID-19: a first perspective. Safety concerns of clinical images and skin biopsies.","We have read with great interest the article: Cutaneous manifestations in COVID-19: a first perspective by Recalcati S.(1) This article is the first report of the cutaneous manifestations in Coronavirus Disease 2019 (COVID-19) patients during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic in Lombardy, Italy.","J Eur Acad Dermatol Venereol","Fernandez-Nieto, D","Ortega-Quijano, D","Segurado-Miravalles, G","Pindado-Ortega, C","Prieto-Barrios, M","Jimenez-Cauhe, J","32294262"],"abstract":["We have read with great interest the article: Cutaneous manifestations in COVID-19: a first perspective by Recalcati S.(1) This article is the first report of the cutaneous manifestations in Coronavirus Disease 2019 (COVID-19) patients during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic in Lombardy, Italy."],"journal":"J Eur Acad Dermatol Venereol","authors":["Fernandez-Nieto, D","Ortega-Quijano, D","Segurado-Miravalles, G","Pindado-Ortega, C","Prieto-Barrios, M","Jimenez-Cauhe, J"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32294262","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1111/jdv.16470","keywords":["covid-19","exanthem","rash","skin","virus"],"locations":["Lombardy","Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"weight":0,"_version_":1666138494328635393,"score":44.20267},{"pmid":32330336,"title":"SARS-CoV-2 infection presenting as a febrile rash.","text":["SARS-CoV-2 infection presenting as a febrile rash.","The World Health Organization (WHO) has declared that Coronavirus disease 2019 (Covid-19) is a public health emergency of international concern as it continues to spread worldwide.(1) After a median incubation period of 4 days, fever and cough are the two most common manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.","J Eur Acad Dermatol Venereol","Amatore, F","Macagno, N","Mailhe, M","Demarez, B","Gaudy-Marqueste, C","Grob, J J","Raoult, D","Brouqui, P","Richard, M A","32330336"],"abstract":["The World Health Organization (WHO) has declared that Coronavirus disease 2019 (Covid-19) is a public health emergency of international concern as it continues to spread worldwide.(1) After a median incubation period of 4 days, fever and cough are the two most common manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection."],"journal":"J Eur Acad Dermatol Venereol","authors":["Amatore, F","Macagno, N","Mailhe, M","Demarez, B","Gaudy-Marqueste, C","Grob, J J","Raoult, D","Brouqui, P","Richard, M A"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330336","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/jdv.16528","keywords":["covid-19","sars-cov-2","cutaneous manifestation","rash"],"topics":["Case Report"],"weight":1,"_version_":1666138494549884929,"score":44.20267},{"pmid":32358895,"title":"Histological pattern in Covid-19 induced viral rash.","text":["Histological pattern in Covid-19 induced viral rash.","as stated by Estebanez et al(1) , incidence of dermatological affection in covid-19 patients may be different than reported until now. Datas and evidences are building up every day and we wanted to add a contribution describing the case of a 67-year-old patient, caucasian, with moderate obesity, a history of alcoholism and various chronic morbidities. No drug allergy was referred. She was sent to ER due to progressive dyspnoea and fever: after RT-PCR resulted positive to SARS-CoV 2, she was admitted to hospital and then intubated a week later due to worsening of the respiratory condition.","J Eur Acad Dermatol Venereol","Zengarini, Corrado","Orioni, Gionathan","Cascavilla, Alessandra","Horna Solera, Clara","Fulgaro, Ciro","Misciali, Cosimo","Patrizi, Annalisa","Gaspari, Valeria","32358895"],"abstract":["as stated by Estebanez et al(1) , incidence of dermatological affection in covid-19 patients may be different than reported until now. Datas and evidences are building up every day and we wanted to add a contribution describing the case of a 67-year-old patient, caucasian, with moderate obesity, a history of alcoholism and various chronic morbidities. No drug allergy was referred. She was sent to ER due to progressive dyspnoea and fever: after RT-PCR resulted positive to SARS-CoV 2, she was admitted to hospital and then intubated a week later due to worsening of the respiratory condition."],"journal":"J Eur Acad Dermatol Venereol","authors":["Zengarini, Corrado","Orioni, Gionathan","Cascavilla, Alessandra","Horna Solera, Clara","Fulgaro, Ciro","Misciali, Cosimo","Patrizi, Annalisa","Gaspari, Valeria"],"date":"2020-05-03T11:00:00Z","year":2020,"_id":"32358895","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/jdv.16569","keywords":["covid-19","rash","cutaneous","exanthema","histology","skin"],"topics":["Case Report"],"weight":1,"_version_":1666138495332122625,"score":44.20267}]}